Guardian Pharmacy Services (GRDN) Competitors $25.01 -0.03 (-0.12%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock GRDN vs. FCFS, MNSO, RUSHB, W, TBBB, BOOT, ASO, CSAN, GO, and SVVShould you be buying Guardian Pharmacy Services stock or one of its competitors? The main competitors of Guardian Pharmacy Services include FirstCash (FCFS), MINISO Group (MNSO), Rush Enterprises (RUSHB), Wayfair (W), BBB Foods (TBBB), Boot Barn (BOOT), Academy Sports and Outdoors (ASO), Cosan (CSAN), Grocery Outlet (GO), and Savers Value Village (SVV). These companies are all part of the "retail" industry. Guardian Pharmacy Services vs. FirstCash MINISO Group Rush Enterprises Wayfair BBB Foods Boot Barn Academy Sports and Outdoors Cosan Grocery Outlet Savers Value Village Guardian Pharmacy Services (NYSE:GRDN) and FirstCash (NASDAQ:FCFS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment, community ranking and analyst recommendations. Does the MarketBeat Community believe in GRDN or FCFS? FirstCash received 14 more outperform votes than Guardian Pharmacy Services when rated by MarketBeat users. However, 100.00% of users gave Guardian Pharmacy Services an outperform vote while only 42.22% of users gave FirstCash an outperform vote. CompanyUnderperformOutperformGuardian Pharmacy ServicesOutperform Votes5100.00% Underperform VotesNo VotesFirstCashOutperform Votes1942.22% Underperform Votes2657.78% Do institutionals & insiders have more ownership in GRDN or FCFS? 80.3% of FirstCash shares are held by institutional investors. 63.7% of Guardian Pharmacy Services shares are held by insiders. Comparatively, 14.8% of FirstCash shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, GRDN or FCFS? FirstCash has higher revenue and earnings than Guardian Pharmacy Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardian Pharmacy Services$1.23B1.29N/AN/AN/AFirstCash$3.39B1.77$258.82M$6.2521.43 Is GRDN or FCFS more profitable? FirstCash has a net margin of 7.64% compared to Guardian Pharmacy Services' net margin of 0.00%. FirstCash's return on equity of 14.99% beat Guardian Pharmacy Services' return on equity.Company Net Margins Return on Equity Return on Assets Guardian Pharmacy ServicesN/A N/A N/A FirstCash 7.64%14.99%6.94% Do analysts rate GRDN or FCFS? Guardian Pharmacy Services currently has a consensus target price of $22.33, indicating a potential downside of 10.60%. FirstCash has a consensus target price of $133.50, indicating a potential downside of 0.34%. Given FirstCash's higher probable upside, analysts plainly believe FirstCash is more favorable than Guardian Pharmacy Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardian Pharmacy Services 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00FirstCash 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media favor GRDN or FCFS? In the previous week, FirstCash had 15 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 19 mentions for FirstCash and 4 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.69 beat FirstCash's score of 1.26 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive FirstCash 13 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryFirstCash beats Guardian Pharmacy Services on 9 of the 14 factors compared between the two stocks. Get Guardian Pharmacy Services News Delivered to You Automatically Sign up to receive the latest news and ratings for GRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRDN vs. The Competition Export to ExcelMetricGuardian Pharmacy ServicesDrug stores & proprietary stores IndustryMedical SectorNYSE ExchangeMarket Cap$1.58B$10.36B$5.56B$18.97BDividend YieldN/A6.73%5.11%4.02%P/E RatioN/A71.3122.4832.71Price / Sales1.290.32394.5627.84Price / CashN/A67.5038.1817.53Price / BookN/A0.786.774.47Net IncomeN/A-$585.83M$3.22B$1.02B7 Day Performance3.98%-0.40%1.48%0.50%1 Month Performance18.38%-0.88%3.99%-2.83%1 Year PerformanceN/A-9.76%16.15%4.36% Guardian Pharmacy Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRDNGuardian Pharmacy Services0.7003 of 5 stars$25.01-0.1%$22.33-10.7%N/A$1.57B$1.23B0.003,200Positive NewsFCFSFirstCash4.2424 of 5 stars$120.42-0.8%$135.67+12.7%+18.6%$5.39B$3.39B21.0218,000Earnings ReportPositive NewsMNSOMINISO Group4.3217 of 5 stars$15.93+1.9%$26.03+63.4%-19.5%$4.98B$16.99B14.353,370Short Interest ↑Positive NewsRUSHBRush Enterprises1.9023 of 5 stars$56.29-3.1%N/A+41.4%$4.60B$7.80B15.098,040Earnings ReportPositive NewsWWayfair4.062 of 5 stars$25.87-2.8%$52.92+104.6%-40.2%$3.28B$11.85B-6.4415,700Analyst ForecastShort Interest ↑Gap UpTBBBBBB Foods2.4196 of 5 stars$26.90+3.5%$33.67+25.2%+32.6%$3.07B$57.44B0.0021,924Positive NewsBOOTBoot Barn4.6375 of 5 stars$89.50-2.2%$175.62+96.2%-2.2%$2.74B$1.85B15.988,400Analyst ForecastASOAcademy Sports and Outdoors4.5493 of 5 stars$36.78-2.8%$58.63+59.4%-35.4%$2.46B$5.93B6.0422,000Analyst ForecastShort Interest ↓Positive NewsCSANCosan4.9001 of 5 stars$4.86-1.0%$19.00+290.9%-50.8%$2.27B$43.95B3.6811,656Short Interest ↓News CoveragePositive NewsGOGrocery Outlet2.764 of 5 stars$15.74+3.8%$15.46-1.8%-35.3%$1.54B$4.37B30.86950Upcoming EarningsAnalyst ForecastPositive NewsSVVSavers Value Village2.4128 of 5 stars$9.42+3.7%$11.67+23.8%-42.1%$1.50B$1.54B52.3422,000News CoveragePositive News Related Companies and Tools Related Companies FirstCash Alternatives MINISO Group Alternatives Rush Enterprises Alternatives Wayfair Alternatives BBB Foods Alternatives Boot Barn Alternatives Academy Sports and Outdoors Alternatives Cosan Alternatives Grocery Outlet Alternatives Savers Value Village Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GRDN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRDN Stock Free GRDN Stock Alerts